Comparison of the impact of trans fatty acids from ruminant and industrial sources on surrogate markers of cholesterol homeostasis in healthy men

Molecular Nutrition and Food Research

Volumn 55, Issue SUPPL. 2, 2011, Pages

  Labonté, Marie Ève ^a   Couture, Patrick ^a,b   Paquin, Paul ^a   Chouinard, Yvan ^a   Lemieux, Simone ^a   Lamarche, Benoît ^a  

^a LAVAL UNIVERSITY   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

Campesterol; Cholesterol homeostasis; Lathosterol; Sitosterol; Trans fatty acids

Indexed keywords

BIOLOGICAL MARKER; CAMPESTEROL; CHOLESTEROL; DRUG DERIVATIVE; PHYTOSTEROL; SITOSTEROL; SITOSTEROL DERIVATIVE; TRANS FATTY ACID;

ADOLESCENT; ADULT; AGED; ANIMAL; ARTICLE; BLOOD; BOVIDS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HOMEOSTASIS; HUMAN; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; ANIMALS; BIOLOGICAL MARKERS; CHOLESTEROL; DOUBLE-BLIND METHOD; HOMEOSTASIS; HUMANS; MALE; MIDDLE AGED; PHYTOSTEROLS; RUMINANTS; SITOSTEROLS; TRANS FATTY ACIDS; YOUNG ADULT;

EID: 80053223071     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201000492     Document Type: Article

References (43)

1. Micha, R., Mozaffarian, D., Trans fatty acids: effects on metabolic syndrome, heart disease and diabetes. Nat. Rev. Endocrinol. 2009, 5, 335-344.
2. Mozaffarian, D., Katan, M. B., Ascherio, A., Stampfer, M. J., Willett, W. C., Trans fatty acids and cardiovascular disease. N. Engl. J. Med. 2006, 354, 1601-1613.
3. Willett, W. C., Stampfer, M. J., Manson, J. E., Colditz, G. A. et al., Intake of trans fatty acids and risk of coronary heart disease among women. Lancet 1993, 341, 581-585.
4. Ascherio, A., Hennekens, C. H., Buring, J. E., Master, C. et al., Trans-fatty acids intake and risk of myocardial infarction. Circulation 1994, 89, 94-101.
5. Pietinen, P., Ascherio, A., Korhonen, P., Hartman, A. M. et al., Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am. J. Epidemiol. 1997, 145, 876-887.
6. Motard-Belanger, A., Charest, A., Grenier, G., Paquin, P. et al., Study of the effect of trans fatty acids from ruminants on blood lipids and other risk factors for cardiovascular disease. Am. J. Clin. Nutr. 2008, 87, 593-599.
7. Gylling, H., Cholesterol metabolism and its implications for therapeutic interventions in patients with hypercholesterolaemia. Int. J. Clin. Pract. 2004, 58, 859-866.
8. Matthan, N. R., Pencina, M., LaRocque, J. M., Jacques, P. F. et al., Alterations in cholesterol absorption/synthesis markers characterize Framingham Offspring Study participants with CHD. J. Lipid Res. 2009, 50, 1927-1935.
9. Kruit, J. K., Groen, A. K., van Berkel, T. J., Kuipers, F., Emerging roles of the intestine in control of cholesterol metabolism. World J. Gastroenterol. 2006, 12, 6429-6439.
10. Miettinen, T. A., Tilvis, R. S., Kesaniemi, Y. A., Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male-population. Am. J. Epidemiol. 1990, 131, 20-31.
11. Tilvis, R. S., Miettinen, T. A., Serum plant sterols and their relation to cholesterol absorption. Am. J. Clin. Nutr. 1986, 43, 92-97.
12. Kempen, H. J. M., Glatz, J. F. C., Leuven, J. A. G., Vandervoort, H. A., Katan, M. B., Serum lathosterol concentration is an indicator of whole-body cholesterol-synthesis in humans. J. Lipid Res. 1988, 29, 1149-1155.
13. Matthan, N. R., Giovanni, A., Schaefer, E. J., Brown, B. G., Lichtenstein, A. H., Impact of simvastatin, niacin, and/or antioxidants on cholesterol metabolism in CAD patients with low HDL. J. Lipid Res. 2003, 44, 800-806.
14. Assmann, G., Cullen, P., Erbey, J., Ramey, D. R. et al., Plasma sitosterol elevations are associated with an increased incidence of coronary events in men: Results of a nested case-control analysis of the Prospective Cardiovascular Munster (PROCAM) study. Nutr. Metab. Cardiovasc. Dis. 2006, 16, 13-21.
15. Gylling, H., Hallikainen, M., Kolehmainen, M., Toppinen, L. et al., Cholesterol synthesis prevails over absorption in metabolic syndrome. Transl. Res. 2007, 149, 310-316.
16. Simonen, P., Gylling, H., Howard, A. N., Miettinen, T. A., Introducing a new component of the metabolic syndrome: low cholesterol absorption. Am. J. Clin. Nutr. 2000, 72, 82-88.
17. Remig, V., Franklin, B., Margolis, S., Kostas, G. et al., Trans fats in America: a review of their use, consumption, health implications, and regulation. J. Am. Diet Assoc. 2010, 110, 585-592.
18. Normen, L., Johnsson, M., Andersson, H., van Gameren, Y., Dutta, P., Plant sterols in vegetables and fruits commonly consumed in Sweden. Eur. J. Nutr. 1999, 38, 84-89.
19. Normen, L., Bryngelsson, S., Johnsson, M., Evheden, P. et al., The phytosterol content of some cereal foods commonly consumed in Sweden and in the Netherlands. J. Food. Compost. Anal. 2002, 15, 693-704.
20. Lange, W., Cholesterol, phytosterol, and tocopherol content of food products and animal tissues. J. Am. Oil Chem. Soc. 1950, 27, 414-422.
21. Kritchevsky, D. in: Kritchevsky, D., Bonfield, C. (Eds.), Dietary Fiber in Health and Disease, Plenum Press, New York, NY 1997, pp. 235-242.
22. Goulet, J., Nadeau, G., Lapointe, A., Lamarche, B., Lemieux, S., Validity and reproducibility of an interviewer-administered food frequency questionnaire for healthy French-Canadian men and women. Nutr. J. 2004, 3-13.
23. Lohman, T., Roche, A., Martorel, R., in: Lohman, T. G., Roche, A. F., Martorell, R. (Eds.), Anthropometric Standardization Reference Manual, Human Kinetics, Champaign, IL 1988, pp. 39-80.
24. Albers, J. J., Warnick, G. R., Wiebe, D., King, P. et al., Multi-laboratory comparison of 3 heparin-Mn2+precipitation procedures for estimating cholesterol in high-density lipoprotein. Clin. Chem. 1978, 24, 853-856.
25. Burstein, M., Samaille, J., Sur un dosage rapide du cholesterol lie aux alpha-lipoproteines et aux beta-lipoproteines du serum. Clin. Chim. Acta 1960, 5, 609.
26. Moorjani, S., Dupont, A., Labrie, F., Lupien, P. J. et al., Increase in plasma high-density-lipoprotein concentration following complete androgen blockage in men with prostatic-carcinoma. Metabolism 1987, 36, 244-250.
27. Couillard, C., Despres, J. P., Lamarche, B., Bergeron, J. et al., Effects of endurance exercise training on plasma HDL cholesterol levels depend on levels of triglycerides - Evidence from men of the health, risk factors, exercise training and genetics (HERITAGE) family study. Arterisocler. Thromb. Vasc. Biol. 2001, 21, 1226-1232.
28. Cuchel, M., Schwab, U. S., Jones, P. J. H., Vogel, S. et al., Impact of hydrogenated fat consumption on endogenous cholesterol synthesis and susceptibility of low-density lipoprotein to oxidation in moderately hypercholesterolemic individuals. Metabolism 1996, 45, 241-247.
29. Matthan, N. R., Ausman, L. M., Lichtenstein, A. H., Jones, P. J. H., Hydrogenated fat consumption affects cholesterol synthesis in moderately hypercholesterolemic women. J. Lipid Res. 2000, 41, 834-839.
30. Sundram, K., French, M. A., Clandinin, M. T., Exchanging partially hydrogenated fat for palmitic acid in the diet increases LDL-cholesterol and endogenous cholesterol synthesis in normocholesterolemic women. Eur. J. Nutr. 2003, 42, 188-194.
31. Chardigny, J. M., Destaillats, F., Malpuech-Brugere, C., Moulin, J. et al., Do trans fatty acids from industrially produced sources and from natural sources have the same effect on cardiovascular disease risk factors in healthy subjects? Results of the trans Fatty Acids Collaboration (TRANSFACT) study. Am. J. Clin. Nutr. 2008, 87, 558-566.
32. Jakobsen, M. U., Overvad, K., Dyerberg, J., Heitmann, B. L., Intake of ruminant trans fatty acids and risk of coronary heart disease. Int. J. Epidemiol. 2008, 37, 173-182.
33. Mozaffarian, D., Willett, W. C., Trans fatty acids and cardiovascular risk: a unique cardiometabolic imprint? Curr. Atheroscler. Rep. 2007, 9, 486-493.
34. Simonen, P. P., Gylling, H. K., Miettinen, T. A., Diabetes contributes to cholesterol metabolism regardless of obesity. Diabetes Care 2002, 25, 1511-1515.
35. Griinari, J. M., Corl, B. A., Lacy, S. H., Chouinard, P. Y. et al., Conjugated linoleic acid is synthesized endogenously in lactating dairy cows by Delta(9)-desaturase. J. Nutr. 2000, 130, 2285-2291.
36. Moya-Camarena, S. Y., Vanden Heuvel, J. P., Blanchard, S. G., Leesnitzer, L. A., Belury, M. A., Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPAR alpha. J. Lipid Res. 1999, 40, 1426-1433.
37. Li, T., Chiang, J. Y. L., Regulation of Bile Acid and Cholesterol Metabolism by PPARs. PPAR Res. 2009, 2009, 1-15.
38. Davis, H. R., Zhu, L. J., Hoos, L. M., Tetzloff, G. et al., Niemann-Pick C1 like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis. J. Biol. Chem. 2004, 279, 33586-33592.
39. Mozaffarian, D., Trans fatty acids - effects on systemic inflammation and endothelial function. Atheroscler. Suppl. 2006, 7, 29-32.
40. Niu, S. L., Mitchell, D. C., Litman, B. J., Trans fatty acid derived phospholipids show increased membrane cholesterol and reduced receptor activation as compared to their cis analogs. Biochemistry 2005, 44, 4458-4465.
41. Matthan, N. R., Welty, F. K., Barrett, P. H. R., Harausz, C. et al., Dietary hydrogenated fat increases high-density lipoprotein apoA-I catabolism and decreases low-density lipoprotein apoB-100 catabolism in hypercholesterolemic women. Arterioscler. Thromb. Vasc. Biol. 2004, 24, 1092-1097.
42. Santosa, S., Varady, K. A., AbuMweis, S., Jones, P. J. H., Physiological and therapeutic factors affecting cholesterol metabolism: does a reciprocal relationship between cholesterol absorption and synthesis really exist? Life Sci. 2007, 80, 505-514.
43. Nissinen, M. J., Gylling, H., Miettinen, T. A., Responses of surrogate markers of cholesterol absorption and synthesis to changes in cholesterol metabolism during various amounts of fat and cholesterol feeding among healthy men. Br. J. Nutr. 2008, 99, 370-378.